Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease
Abdel Ali Belaidi, Ashley I Bush, Scott Ayton · 2025
Read Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease by Abdel Ali Belaidi, Ashley I Bush, Scott Ayton (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710517.txt.
Description
Apolipoprotein E is the biggest genetic lever on Alzheimer's risk after age itself, yet how it harms the brain is still unsettled. Abdel Ali Belaidi, Ashley Bush, and Scott Ayton report experiments in 2025 on one of its receptors, APOER2, as a possible drug target.
Working with neuron cells, the team triggered a form of cell death called ferroptosis, driven by iron and damaged fats. Neurons carrying the receptor raised their levels of a protective enzyme, GPX4, which defuses those damaged fats, and they resisted death better when APOE was present. The authors read this as a teamwork effect: the protein and its receptor jointly guard neurons, a route that drugs might strengthen.
Catalog record
| CREATOR | Abdel Ali Belaidi, Ashley I Bush, Scott Ayton |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |